Kaleido Stock Buy Hold or Sell Recommendation

KLDO -  USA Stock  

USD 2.33  0.10  4.48%

Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Kaleido Biosciences is 'Strong Sell'. Macroaxis provides Kaleido Biosciences buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding KLDO positions. The advice algorithm takes into account all of Kaleido Biosciences' available fundamental, technical, and predictive indicators you will find on this site.

Kaleido Advice 

 
Refresh
The advice is provided from Kaleido Biosciences' buy-and-hold perspective. Please see Kaleido Biosciences Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. We conduct extensive research on individual companies such as Kaleido and provide practical buy, sell, or hold advice based on selected investing horizon and risk tolerance towards Kaleido Biosciences.

Execute Kaleido Biosciences Buy or Sell Advice

The Kaleido recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Kaleido Biosciences. Macroaxis does not own or have any residual interests in Kaleido Biosciences or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Kaleido Biosciences' advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Kaleido BiosciencesBuy Kaleido Biosciences
Strong Sell

Volatility

UnstableDetails

Hype Condition

Over hypedDetails

Current Valuation

UndervaluedDetails

Odds of Distress

HighDetails

Economic Sensitivity

Barely shadows the marketDetails

Analyst Consensus

HoldDetails

Financial Strenth (F Score)

FrailDetails

Financial Leverage

InapplicableDetails

Reporting Quality (M-Score)

Unlikely ManipulatorDetails
For the selected time horizon Kaleido Biosciences has a Mean Deviation of 4.62, Standard Deviation of 5.77 and Variance of 33.24
We provide investment recommendation to complement the last-minute expert consensus on Kaleido Biosciences. Our dynamic recommendation engine harnesses a multidimensional algorithm to analyze the entity's potential to grow using all technical and fundamental data available at the time. To make sure Kaleido Biosciences is not overpriced, please verify all Kaleido Biosciences fundamentals, including its revenue, cash flow from operations, current liabilities, as well as the relationship between the cash per share and market capitalization . Please also check out Kaleido Biosciences price to book to check your buy or sell decision is consistent with all fundamental data available and that the company can sustain itself in the current economic cycle.

Kaleido Biosciences Trading Alerts and Improvement Suggestions

Kaleido Biosciences generated a negative expected return over the last 90 days
Kaleido Biosciences has high historical volatility and very poor performance
Kaleido Biosciences has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 855 K. Net Loss for the year was (90.03 M) with loss before overhead, payroll, taxes, and interest of (54.99 M).
Kaleido Biosciences currently holds about 55.66 M in cash with (71.23 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.31.
Kaleido Biosciences has a frail financial position based on the latest SEC disclosures
Over 82.0% of the company shares are owned by institutional investors
Latest headline from www.marketscreener.com: Kaleido Biosciences to Present Updated Data of KB295 In Ulcerative Colitis at the 2022 Crohns and Colitis Congress - marketscreener.com

Kaleido Biosciences current analysts advice

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Kaleido analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Kaleido analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Mean Price14.80
Target Median Price19.00
Target High Price22.00
Recommendation Mean2.50
Number Of Analyst Opinions5
Target Low Price3.00
Average Consensus Hold
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.

Kaleido Biosciences Returns Distribution Density

The distribution of Kaleido Biosciences' historical returns is an attempt to chart the future uncertainty of Kaleido Biosciences' future price movements. The chart of the probability distribution of Kaleido Biosciences stock daily returns describes the distribution of returns around its average expected value. We use Kaleido Biosciences price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Kaleido Biosciences returns is essential to provide solid investment advice for Kaleido Biosciences stock.
Mean Return-1.25Value At Risk-9.18
Potential Upside6.19Standard Deviation5.77
 Return Density 
      Distribution 
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Kaleido Biosciences historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Kaleido Biosciences Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Kaleido Biosciences or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Kaleido Biosciences stock's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Kaleido stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over DOW
-1.24
β
Beta against DOW0.12
σ
Overall volatility
5.60
Ir
Information ratio -0.18

Kaleido Biosciences Volatility Alert

Kaleido Biosciences exhibits very low volatility with skewness of 0.49 and kurtosis of 0.16. However, we advise investors to further study Kaleido Biosciences technical indicators to make sure all market info is available and is reliable. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Kaleido Biosciences' stock risk against market volatility during both bullying and bearish trends. The higher level of volatility that comes with bear markets can directly impact Kaleido Biosciences' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

Kaleido Biosciences Implied Volatility

Kaleido Biosciences' implied volatility exposes the market's sentiment of Kaleido Biosciences stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Kaleido Biosciences' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Kaleido Biosciences stock will not fluctuate a lot when Kaleido Biosciences' options are near their expiration.

Kaleido Biosciences Fundamentals Vs Peers

Comparing Kaleido Biosciences' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Kaleido Biosciences' direct or indirect competition across all of the common fundamentals between Kaleido Biosciences and the related equities. This way, we can detect undervalued stocks with similar characteristics as Kaleido Biosciences or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Kaleido Biosciences' fundamental indicators could also be used in its relative valuation, which is a method of valuing Kaleido Biosciences by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Kaleido Biosciences to competition
FundamentalsKaleido BiosciencesPeer Average
Return On Equity(276.59) %(0.31) %
Return On Asset(77.39) %(0.14) %
Current Valuation76.6 M16.62 B
Shares Outstanding42.59 M571.82 M
Shares Owned by Insiders4.71 %10.09 %
Shares Owned by Institutions81.80 %39.21 %
Number of Shares Shorted2.21 M4.71 M
Price to Earning(1.45) X28.72 X
Price to Book3.15 X9.51 X
Price to Sales107.61 X11.42 X
Revenue855 K9.43 B
Gross Profit(54.99 M)27.38 B
EBITDA(84.95 M)3.9 B
Net Income(90.03 M)570.98 M
Cash and Equivalents55.66 M2.7 B
Cash per Share1.31 X5.01 X
Total Debt21.52 M5.32 B
Debt to Equity0.74 %48.70 %
Current Ratio3.03 X2.16 X
Book Value Per Share0.69 X1.93 K
Cash Flow from Operations(71.23 M)971.22 M
Short Ratio15.12 X4.00 X
Earnings Per Share(2.24) X3.12 X
Number of Employees8218.84 K
Beta-0.28-0.15
Market Capitalization92 M19.03 B
Total Asset81.6 M29.47 B
Retained Earnings(197.63 M)9.33 B
Working Capital62.54 M1.48 B
Current Asset72.93 M9.34 B
Current Liabilities10.39 M7.9 B
Z Score-3.78.72
   Acquisition by Long Alison S of 125000 shares of Kaleido Biosciences subject to Rule 16b-3 [view details]

Kaleido Biosciences Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Kaleido . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
Accumulation Distribution97.3
Daily Balance Of Power2.5
Rate Of Daily Change1.04
Day Median Price2.31
Day Typical Price2.32
Market Facilitation Index0.0
Price Action Indicator0.07

About Kaleido Biosciences Buy or Sell Advice

When is the right time to buy or sell Kaleido Biosciences? Buying financial instruments such as Kaleido Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the stock market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Although Kaleido Biosciences investors may find it confusing at the beginning, most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
 2019 2020 2021 2022 (projected)
Current Assets73.28 M48.72 M56.03 M62.31 M
Total Assets82.31 M59.34 M68.25 M73.22 M

Use Investing Ideas to Build Portfolios

In addition to having Kaleido Biosciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Healthcare Thematic Idea Now

Healthcare
Healthcare Theme
Fama and French focuses on testing asset pricing under different economic assumptions. Healthcare theme has 61 constituents.
View All  Next Launch Healthcare
Please see Kaleido Biosciences Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note that the Kaleido Biosciences information on this page should be used as a complementary analysis to other Kaleido Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Piotroski F Score module to get Piotroski F Score based on binary analysis strategy of nine different fundamentals.

Complementary Tools for Kaleido Stock analysis

When running Kaleido Biosciences price analysis, check to measure Kaleido Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kaleido Biosciences is operating at the current time. Most of Kaleido Biosciences' value examination focuses on studying past and present price action to predict the probability of Kaleido Biosciences' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Kaleido Biosciences' price. Additionally, you may evaluate how the addition of Kaleido Biosciences to your portfolios can decrease your overall portfolio volatility.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Go
Is Kaleido Biosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Kaleido Biosciences. If investors know Kaleido will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Kaleido Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Kaleido Biosciences is measured differently than its book value, which is the value of Kaleido that is recorded on the company's balance sheet. Investors also form their own opinion of Kaleido Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Kaleido Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kaleido Biosciences' market value can be influenced by many factors that don't directly affect Kaleido Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kaleido Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine Kaleido Biosciences value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kaleido Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.